CorMedix Inc. (CRMD) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
300 CONNELL DRIVE BERKELEY HEIGHTS, NJ 07922 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 76,031 | 58,792 | 65,466 | 46,350 | 28,334 | 17,624 | |||
| Cash and cash equivalents | 43,643 | 43,148 | 53,317 | 41,905 | 16,350 | 17,624 | |||
| Short-term investments | 32,388 | 15,644 | 12,149 | 4,444 | 11,984 | ||||
| Restricted cash and investments | 77 | 124 | 132 | 191 | |||||
| Receivables | 11 | ||||||||
| Inventory, net of allowances, customer advances and progress billings | 2,106 | 3 | 144 | 338 | 429 | ||||
| Inventory | 2,106 | 3 | 144 | 338 | 429 | ||||
| Prepaid expense | 354 | 11 | 52 | 62 | 35 | 8 | |||
| Deposits current assets | 20 | ||||||||
| Other undisclosed current assets | 882 | 624 | 816 | 1,416 | 641 | 594 | |||
| Total current assets: | 79,450 | 59,551 | 66,469 | 48,182 | 29,349 | 18,665 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 640 | 775 | 900 | 1,015 | ✕ | ||||
| Property, plant and equipment | 1,866 | 1,610 | 1,475 | 111 | 127 | 161 | |||
| Restricted cash and investments | 103 | 102 | 102 | ||||||
| Other undisclosed noncurrent assets | |||||||||
| Total noncurrent assets: | 2,610 | 2,487 | 2,477 | 1,126 | 127 | 161 | |||
| TOTAL ASSETS: | 82,060 | 62,038 | 68,946 | 49,308 | 29,476 | 18,826 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 11,250 | 6,176 | 5,224 | 4,052 | 5,825 | 7,755 | |||
| Accounts payable | 4,280 | 2,202 | 2,210 | 1,128 | 1,024 | 2,589 | |||
| Accrued liabilities | 6,970 | 3,974 | 3,014 | 2,924 | 4,800 | 5,166 | |||
| Deferred revenue | 2 | ✕ | |||||||
| Other undisclosed current liabilities | 151 | 135 | 121 | 109 | 11 | ||||
| Total current liabilities: | 11,401 | 6,311 | 5,345 | 4,162 | 5,827 | 7,766 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 802 | 924 | 3 | 6,125 | |||||
| Long-term debt, excluding current maturities | 6,125 | ||||||||
| Liabilities, other than long-term debt | 517 | 668 | |||||||
| Operating lease, liability | 517 | 668 | 802 | 924 | 3 | ✕ | |||
| Other undisclosed noncurrent liabilities | (802) | (924) | |||||||
| Total noncurrent liabilities: | 517 | 668 | 802 | 924 | 3 | 6,125 | |||
| Total liabilities: | 11,918 | 6,979 | 6,148 | 5,085 | 5,830 | 13,892 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 70,142 | 55,060 | 62,798 | 44,223 | 23,646 | 4,934 | |||
| Preferred stock | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Common stock | 55 | 43 | 38 | 34 | 26 | 109 | |||
| Common stock, value, subscriptions | 15,200 | ||||||||
| Additional paid in capital | 391,693 | 330,295 | 308,332 | 261,536 | 6 | 183,717 | |||
| Accumulated other comprehensive income | 94 | 83 | 87 | 102 | 97 | 97 | |||
| Accumulated deficit | (321,700) | (275,361) | (245,659) | (217,449) | (195,421) | (178,988) | |||
| Other undisclosed equity, attributable to parent | 203,738 | ||||||||
| Total equity: | 70,142 | 55,060 | 62,798 | 44,223 | 23,646 | 4,934 | |||
| TOTAL LIABILITIES AND EQUITY: | 82,060 | 62,038 | 68,946 | 49,308 | 29,476 | 18,826 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 65 | 191 | 239 | 283 | 430 | |||
| Other income | ||||||||
| Cost of revenue | (4) | (149) | (205) | (373) | (397) | |||
| Gross profit: | 62 | 42 | 34 | (90) | 33 | |||
| Operating expenses | (48,958) | (30,686) | (29,480) | (27,255) | (20,918) | (26,897) | ||
| Other operating expense, net (Other Expenses) | (2) | |||||||
| Other undisclosed operating income | 2 | |||||||
| Operating loss: | (48,958) | (30,624) | (29,438) | (27,221) | (21,008) | (26,864) | ||
| Nonoperating income (expense) | 2,619 | 337 | (23) | 24 | 302 | 35 | ||
| Investment income, nonoperating | 323 | |||||||
| Other nonoperating income (expense) | 2,619 | 337 | (23) | 24 | 35 | |||
| Interest and debt expense | (34) | (27) | (16) | (33) | (787) | (2) | ||
| Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | 33 | (0) | 2 | |||||
| Loss from continuing operations before equity method investments, income taxes: | (46,374) | (30,314) | (29,476) | (27,197) | (21,494) | (26,830) | ||
| Other undisclosed income from continuing operations before income taxes | 27 | 16 | 0 | |||||
| Loss from continuing operations before income taxes: | (46,374) | (30,287) | (29,460) | (27,197) | (21,494) | (26,830) | ||
| Income tax benefit | 586 | 1,250 | 5,169 | 5,061 | ||||
| Other undisclosed income from continuing operations | 34 | |||||||
| Loss from continuing operations: | (46,339) | (29,702) | (28,210) | (22,028) | (16,433) | (26,830) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (28,210) | (22,028) | (16,433) | (26,830) | |
| Net loss: | (46,339) | (29,702) | (28,210) | (22,028) | (16,433) | (26,830) | ||
| Net loss attributable to noncontrolling interest | (28,200) | |||||||
| Other undisclosed net income (loss) attributable to parent | 28,200 | |||||||
| Net loss attributable to parent: | (46,339) | (29,702) | (28,210) | (22,028) | (16,433) | (26,830) | ||
| Other undisclosed net loss available to common stockholders, basic | (27,103) | |||||||
| Net loss available to common stockholders, diluted: | (46,339) | (29,702) | (28,210) | (22,028) | (43,536) | (26,830) | ||
Comprehensive Income ($ in thousands)
| 6/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (46,339) | (29,702) | (28,210) | (22,028) | (16,433) | (26,830) | ||
| Other comprehensive income (loss) | 11 | (4) | (15) | 5 | 1 | (2) | ||
| Comprehensive loss: | (46,328) | (29,706) | (28,225) | (22,023) | (16,432) | (26,832) | ||
| Comprehensive loss, net of tax, attributable to noncontrolling interest | (28,200) | |||||||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 28,200 | |||||||
| Comprehensive loss, net of tax, attributable to parent: | (46,328) | (29,706) | (28,225) | (22,023) | (16,432) | (26,832) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.